Activity in human breast cancer cell lines: N(ω)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3305-3312

  Singh, Rajan ^b   Pervin, Shehla ^b   Karimi, Ardeshir ^b   Cederbaum, Stephen ^b   Chaudhuri, Gautam ^a,b  

^a Depts Obstet Gynecol Med M   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; N(G) HYDROXYARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; POLYAMINE; PROTEIN P21; SPERMINE; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; DNA FRAGMENT; DRUG DERIVATIVE; ENZYME INHIBITOR; N(OMEGA) HYDROXYARGININE; N(OMEGA)-HYDROXYARGININE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST CANCER; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; ENZYMOLOGY; FLOW CYTOMETRY; METABOLISM; NICK END LABELING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; ARGINASE; ARGININE; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 3; CASPASES; CELL CYCLE; CELL DIVISION; DNA FRAGMENTATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPERMINE; TUMOR CELLS, CULTURED;

EID: 0034658924     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Jenkinson, C. P., Grody, W. W., and Cederbaum, S. D. Comparative properties of arginases. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 114: 107-132, 1996.
2. Pegg, A. E. Polyamine metabolism and function. Am. J. Physiol., 243: C212-C221, 1982.
3. Chanda, R., and Ganguly, A. K. Polyamines in relation to human breast, rectal and squamous cell carcinoma. Cancer Lett., 39: 311-318, 1988.
4. Manni, A. Polyamines and hormonal control of breast cancer growth. Crit. Rev. Oncog., 1: 163-174, 1989.
5. Manni, A., and Wright, C. Reversal of the antiproliferative effect of the antiestrogen tamoxifen by polyamines in breast cancer cells. Endocrinology, 114: 836-839, 1984.
6. Radomski, M. W., Jenkins, D. C., Holmes, L., and Moncada, S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 51: 6073-6078, 1991.
7. Jenkins, D., C., Charles, I. G., Baylis, S. A., Lelchuk, R., Radomski, M. W., and Moncada, S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer, 70: 847-849, 1994.
8. Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V., and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54: 1352-1354, 1994.
9. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R, G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer. 72: 41-44, 1905.
10. Zeillinger, R., Tantscher, E., Schneeberger, C., Tschugguel, W., Eder, S., Sliutz, G., and Huber, J. C. Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res. Treat., 40: 205-207, 1996.
11. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92: 4392-4396, 1995.
12. Edwards, P., Cendan, J. C., Topping, D. B., Moldawer, L. L., MacKay, S., Copeland, E. M. III, and Lind, D. S. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res., 63: 49-52, 1996.
13. Farias-Eisner, R., Sherman, M. P., Aeberhard, E., and Chaudhuri, G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA, 91: 9407-9411, 1994.
14. Huber, M., and Poulin, R. Antiproliferative effect of spermine depletion by N-cyclohexyl-1,3-diaminopropane in human breast cancer cells. Cancer Res., 55: 934-943, 1995.
15. Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide dependent or independent mechanisms. Cancer Res., 54: 2462-2467, 1994.
16. Daghigh, F., Fukuto, J. M., and Ash, D. E. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun., 202: 174-180, 1994.
17. Hecker, M., Nematollahi, H., Hey, C., Busse, R., and Racke, K. Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett., 359: 251-254, 1995.
18. ID-Hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res, Commun., 203: 1614-1621, 1994.
19. Pegg, A. E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res., 48: 759-767, 1988.
20. Marton, L. J., and Morris, D. R. Molecular and cellular functions of polyamines. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies, pp 79-105. Orlando, FL: Academic Press, 1987.
21. Spector, E. B., Kiernan, M., Bernard, B., and Cederbaum, S. D. Comparative properties of fetal and adult red blood cell arginase: a possible prenatal diagnostic test for arginase deficiency. Am. J. Hum. Genet., 32: 79-87, 1980.
22. Wang, W. W., Jenkinson, C. P., Griscavage, J. M., Kern, R. M., Arabolos, N. S., Byrns, R. E., Cederbaum, S. D., and Ignarro, L. J. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun., 210: 1009-1016, 1995.
23. Singh, R., Pervin, S., Rogers, N. S., Ignarro, L. J., and Chaudhuri, G. Evidence for the presence of unusual nitric oxide and citrulline-producing enzyme in rat kidney. Biochem. Biophys. Res. Commun., 232: 672-677, 1997.
24. Kawamoto, S., Amaya, Y., Murakami, K., Tokunoga, F., Iwanaga, S., Kobayashi, K., Saheki, T., Kimura, S., and Mori, M. Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase. J. Biol. Chem., 262: 6280-6283, 1987.
25. Vockley, J. G., Jenkinson, C. P., Shukla, H., Kern, R. M., Grody, W. W., and Cederbaum, C. D. Cloning and characterization of human type II arginase gene. Genomics, 38: 118-123, 1996.
26. Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M., Sundell, C. L., Wilcox, J. N., Lamas, S., and Michel, T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett., 307: 287-293, 1992.
27. Tso, J. Y., Sun, X. H., Kao, T. H., Reece, K. S., and Wu, R. Isolation and characterization of rat and human glyceraldehyde 3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res., 13: 2485-2502, 1985.
28. Ma, Y., Zhang, R., and Cooper, C. L. Indirect photometric detection of polyamines in biological samples separated by high performance capillary electrophoresis. J. Chromatogr., 608: 93-96, 1992.
29. Piqueras, B., Autran, B., Debre, P., and Gorochov, G. Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. Biotechniques, 20: 634-640, 1996.
30. + suppresses the activation of apoptosis in lymphocytes. J. Biol. Chem., 272: 30567-30576, 1997.
31. Grody, W. W., Dizikes, G. J., and Cederbaum, S. D. Human arginase isozymes. Isozymes Curr. Top. Biol. Med. Res., 13: 181-214, 1987.
32. Griffith, O. W., and Sluehr, D. J. Nitric-oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol., 57: 707-736, 1995.
33. Stuehr, D. J., and Nathan, C. F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169: 1543-1555, 1989.
34. Lepoivre, M., Flaman, J. M., Bobae, P., Lemaire, G., and Henry, Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide: relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J. Biol. Chem., 269: 21891-21897, 1994.
35. 1 regulatory proteins on a breast cancer cell line MDA-MB-231. Proc. Am. Assoc. Cancer Res., 39: 252, 1998.
36. Mills, C. D., Shearer, J., Evans, R., and Caldwell, M. D. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol., 149: 2709-2714, 1992.
37. Hecker, M., Boese, M., Schini-Kerth, V. B., Mulsch, A., and Busse, R. Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as a NG-hydroxy-L-arginine-nitric oxide adduct. Proc. Natl. Acad. Sci. USA, 92: 4671-4675, 1995.
38. Buga, G. M., Singh, R., Pervin, S., Rogers, N. E., Schmitz, D. A., Jenkinson, C. P., Cederbaum, S. D., and Ignarro, L. J. Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am. J. Physiol., 271: H1988-H1998, 1996.
39. Buga, G. M., Wei, L. H., Bauer, P. M., Fukuto, J. M., and Ignarro, L. J. NG-Hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol., 275: RI256-RI264, 1998.
40. Hecker, M., Scott, C., Bucher, B., Busse, R., and Stoclet, J. C. Increase in serum NG-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide. Eur. J. Pharmacol., 275: R1-R3, 1995.
41. Thomas, T., Balabhadrapathruni, S., Gardner, C. R., Hong, J., Faaland, C. A., and Thomas, T. J. Effect of epidermal growth factor on MDA-MB-468 breast cancer cells: Alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1, J. Cell. Physiol., 179: 257-266, 1999.
42. 1/S transition and prolonged S phase within one cell cycle after seeding cells in the presence of an ornithine decarboxylase inhibitor. Cell Prolif., 29: 457-466, 1996.
43. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
44. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
45. Tabor, C. W., and Tabor, H. Polyamines. Annu. Rev. Biochem., 53: 749-790, 1984.
46. Pegg, A. E. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res., 48: 759-774, 1988.
47. Porter, C. W., and Janne, J. Modulation of antineoplastic drug action by inhibitors of polyamine biosynthesis. In: P. P. McCann, A. E. Pegg, and A. Sjoerdsma, (eds.), Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies, pp. 203-248. New York: Academic Press, 1987.
48. Brüne, B., Hartzell, P., Nicotera, P., and Orrenius, S. Spermine prevents endonuclease activation and apoptosis in thymocytes. Exp. Cell Res., 195: 323-329, 1991.
49. Kaneko, H., Hibasami, H., Satoh, N., Wakabayashi, H., Ikeda, H., Tsuge, N., Yonemaru, K., Muraki, A., Kawarada, Y., and Nakashima, K. Involvement of apoptosis and cyclin D1 gene repression in growth inhibition of T-47D human breast cancer cells by methylglyoxal bis(cyclopentylamidinohydrazone). Int. J. Mol. Med., 1: 931-936, 1998.